Enveda Therapeutics
Clinical trials sponsored by Enveda Therapeutics, explained in plain language.
-
New drug trial offers hope for severe eczema sufferers
Disease control Recruiting nowThis study is testing whether a new oral medication called ENV-294 can reduce the severity and extent of moderate-to-severe atopic dermatitis (eczema) over 12 weeks. About 64 adult participants will take either ENV-294 or a placebo pill daily and track their symptoms. Researchers…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 03:51 UTC
-
New pill tested to tame severe asthma attacks
Disease control Recruiting nowThis study is testing a new oral drug called ENV-294 to see if it can help adults whose moderate-to-severe asthma is not fully controlled by their current inhalers. About 50 participants will take either the new drug or a placebo pill daily for 12 weeks. Researchers will check if…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC